By age 75, 50% of men develop an inguinal hernia, which occurs when tissue pushes through weak spots in the abdominal muscles. While surgery is currently the only treatment option with a recurrence rate of 10-15%, a new study from Northwestern Medicine demonstrates potential for a medication-based solution. The research successfully reversed hernias in male mice using an anti-estrogen drug, fulvestrant, showing promise for a human application. Additionally, the study identifies estrogen receptor-alpha as a probable cause of hernia development, paving the way for new treatment strategies.
By age 75, a noteworthy 50 percent of men develop an inguinal (groin) hernia, a bulge from soft tissue pushing through weak abdominal muscles.
This is a blockbuster publication about the first medical treatment of inguinal hernias, suggesting medical repair could be a future option for high-risk male patients.
Collection
[
|
...
]